戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n and its capability to interact with rabbit polyclonal antibody.
2  antibody AB0023 as well as by an anti-LOXL2 polyclonal antibody.
3 terize the NuIP gene product, we developed a polyclonal antibody.
4 2SC-proteins were detected using an anti-2SC polyclonal antibody.
5  (BSA) and a Fab fragment from a BSA-binding polyclonal antibody.
6 uman and pig tissue using a validated GLP-2R polyclonal antibody.
7 ression was further confirmed using anti-B38 polyclonal antibody.
8 25-kDa molecule (p25) recognized by anti-p12 polyclonal antibody.
9 ntracellular ZIKV NS3, using a ZIKV-specific polyclonal antibody.
10 pass those of the original affinity-purified polyclonal antibodies.
11 dotropin (hCG), by using fluorescent-labeled polyclonal antibodies.
12 een receptor binding avidity and escape from polyclonal antibodies.
13 rified rabbit and chicken anti-cPR3(105-201) polyclonal antibodies.
14 pituitary, we generated phosphosite-specific polyclonal antibodies.
15 nd used to obtain the corresponding specific polyclonal antibodies.
16 ly correlated with inhibition of invasion by polyclonal antibodies.
17 probable causes of inhibition of invasion by polyclonal antibodies.
18 eutralization by murine monoclonal and human polyclonal antibodies.
19 e aphid into plant tissues, we produced Me10 polyclonal antibodies.
20 dioimmunohistochemistry analysis using P2X7R polyclonal antibodies.
21 g synthesised and used for the production of polyclonal antibodies.
22 solate distinct OCBs against a background of polyclonal antibodies.
23 nse and produced high titers of high avidity polyclonal antibodies.
24 ere used to derive a panel of monoclonal and polyclonal antibodies.
25 th native-OVA specific monoclonal as well as polyclonal antibodies.
26 pentanoic acid-BSA (SA2-BSA) antigens toward polyclonal antibody (Ab-155).
27 obilized on the uWEs surface toward specific polyclonal antibody (Ab-TC), using a mixture of a fixed
28 hesized as chimeric epitopes to generate two polyclonal antibodies, Ab51 and Ab75.
29 ous" T cell epitope to generate a high titer polyclonal antibody, AbGSC90.
30 "promiscuous" T-cell epitope to generate two polyclonal antibodies, AbGSCA206 and AbGSCB367.
31  fractionated human blood product containing polyclonal antibodies, act as immunomodulator peripheral
32       Importantly, SNV-specific neutralizing polyclonal antibody administered 5 days after SNV infect
33 sates were analyzed by Western blotting with polyclonal antibodies against 2 R-Smad phosphorylation s
34 ISA, and Western blot analysis using chicken polyclonal antibodies against different regions of cochl
35 man monoclonal antibodies (HuMab) and alpaca polyclonal antibodies against each toxin separately and
36                                  Fully human polyclonal antibodies against EBOV were purified and eva
37                                 Biotinylated polyclonal antibodies against Escherichia coli were immo
38 unohistochemical staining was performed with polyclonal antibodies against GLAST and image analysis w
39                     Immunoprecipitation with polyclonal antibodies against human ApoB and ApoE precip
40                          We developed rabbit polyclonal antibodies against human lubricin to determin
41 parasite, we demonstrate that monoclonal and polyclonal antibodies against P. vivax CSP strongly inhi
42                                              Polyclonal antibodies against purified MvaT and MvaU wer
43                            We have developed polyclonal antibodies against rat ATP7A, and we demonstr
44 ocus fused to an epitope tag and by purified polyclonal antibodies against TbVtc4.
45 neutralizing monoclonal antibodies (MAb) and polyclonal antibodies against the DII-FL epitope protect
46                                              Polyclonal antibodies against the extracellular PEAR1 do
47                    None of the monoclonal or polyclonal antibodies against the lectin domain inhibite
48 es important for amyloidogenicity and raised polyclonal antibodies against the most amyloidogenic pep
49   Cryosections of biofilms were treated with polyclonal antibodies against the pneumococcal surface c
50                                              Polyclonal antibodies against TNF-alpha suppressed TLR2/
51                We have produced monospecific polyclonal antibodies against TPH1 and TPH2 using peptid
52 multiple murine tumor growth models in which polyclonal antibodies against tumor antigens, such as Ne
53 ty one commercially available monoclonal and polyclonal antibodies against ZIKV and DENV envelope pro
54 icinus, we show that both a monoclonal and a polyclonal antibody against alpha-Gal stains the gastroi
55  EqCXCL16 or by pretreatment with guinea pig polyclonal antibody against EqCXCL16 protein (Gp anti-Eq
56 egation, whereas the shaft protein FimA or a polyclonal antibody against FimA has no effect.
57                                            A polyclonal antibody against hemoglobin (Hb) immobilized
58 own by immunoblotting using anti-human ADAM8 polyclonal antibody against its prodomain, and the ADAM8
59                                In this study polyclonal antibody against N1 subtype was immobilized o
60                                     A rabbit polyclonal antibody against one of the same epitopes com
61 s were screened by measuring binding to IgG (polyclonal antibody against peanut allergen) and IgE (se
62 re examined by Western blot analysis using a polyclonal antibody against RDH10.
63 ody against ACE, anti-mast cell chymase, and polyclonal antibody against the human AT1R.
64 n airway epithelium was accomplished using a polyclonal antibody against the phosphorylated p65 compo
65 emical staining of paraffin sections using a polyclonal antibody against the protein LIN28A, and (3)
66 12), monoclonal antibodies (aIRR = 1.83), or polyclonal antibodies (aIRR = 2.03); in recipients who w
67                                       Rabbit polyclonal antibodies and commercially available mouse m
68 dditionally, we isolated plasmablast-derived polyclonal antibodies and compared reactivity with plasm
69 t-term inhibition of ectoapyrase activity by polyclonal antibodies and long-term suppression of APY1
70  expressed in Escherichia coli, and specific polyclonal antibodies and polymerase chain reaction (PCR
71 s method utilizes oligonucleotide-conjugated polyclonal antibodies and quantifies antibody-antigen bi
72 ouse lymphatic vessel endothelial receptor-1 polyclonal antibody and a rabbit anti-human von Willebra
73 melamine was employed as a hapten to raise a polyclonal antibody and as the immobilized antigen on th
74 e assay was used to detect CpEF1alpha with a polyclonal antibody and host cell F-actin with rhodamine
75                                     IFN-beta polyclonal antibody and IFN-alpha/beta receptor 1 antibo
76 edicted protein was used to produce specific polyclonal antibodies, and strong immunoreactivity was o
77                  Conventional monoclonal and polyclonal antibodies are sensitive to changes in enviro
78          In conclusion, these data show that polyclonal antibodies are superior to monoclonal antibod
79 using sandwich assay by utilising the rabbit polyclonal antibody as the capture antibody and conjugat
80  absence of NK cells, because treatment with polyclonal antibody asialogangloside GM-1 did not augmen
81 1 monoclonal antibody against HER2 or with a polyclonal-antibody assay kit and fluorescence in situ h
82 th the neutralizing activity of a chimpanzee polyclonal antibody at E2 residues 412 to 426, as it did
83 cipients who received induction therapy with polyclonal antibody, ATGAM (n=127) or Thymoglobulin (n=7
84 AFLAC concentrations were determined using a polyclonal antibody-based enzyme-linked immunosorbent as
85 search on novel approaches to produce potent polyclonal antibody-based therapies have been deficient.
86                                  Recently, a polyclonal-antibody-based in vitro diagnostic (IVD) kit
87               The procedure can use a single polyclonal antibody batch for each target protein, simpl
88         To address the unmet needs for human polyclonal antibodies both as therapeutics and diagnosti
89 a positive correlation with the anti-cod PAV polyclonal antibody, but no correlation with the anti-ca
90     Treatment with anti-guinea pig TNF-alpha polyclonal antibody completely abolished the response of
91  RNA immunoprecipitation assays) using m(6)A polyclonal antibodies coupled with mRNA isolation, quant
92                                        While polyclonal antibodies cross react strongly with RCA120,
93                       Commercially available polyclonal antibodies cross-reacted with other orthopoxv
94                               BvSTI-specific polyclonal antibodies cross-reacted with the expected 30
95 oped and characterized a novel rat/mouse CRF polyclonal antibody (CURE ab 200101) that was used to de
96      In parallel, after initial studies with polyclonal antibodies demonstrated the technical feasibi
97                                              Polyclonal antibodies, derived from humans or hyperimmun
98                              Specific rabbit polyclonal antibodies detected US17 and US18 beginning 5
99 H antibodies retained more reactivity than a polyclonal antibody developed to the same target analyte
100 F;1 expression were detected with either the polyclonal antibody developed using the CDKF;1 protein o
101 s, whereas anti-myeloperoxidase (MPO) mAb or polyclonal antibodies did not.
102  were assessed by western blotting using our polyclonal antibody directed against NDCBE.
103 dulla were examined by immunolabeling with a polyclonal antibody directed against nNOS.
104 uman hippocampi were stained with a specific polyclonal antibody directed against RAGE (Research Diag
105 t an 18-mer peptide sequence of AceCS1 and a polyclonal antibody directed against recombinant AceCS1
106                By using an affinity-purified polyclonal antibody directed against the zebra finch CB(
107                        Passively transferred polyclonal antibodies elicited to nHgbA bound the surfac
108                         Finally, anti-rHyr1p polyclonal antibodies enhanced mouse neutrophil killing
109 affinity enrichment using a non-neutralizing polyclonal antibody followed by digestion and quantitati
110                                              Polyclonal antibodies for each of six enzymes involved i
111 d from LGG-s, analyzed, and used to generate polyclonal antibodies for immunodepletion of respective
112  viral protein 40 antigen was used to derive polyclonal antibodies for RDT and enzyme-linked immunoso
113 tion, the proposed method uses two identical polyclonal antibodies for the sandwich immunoassay, simp
114                           Use of antipeptide polyclonal antibodies for TRP, TRPL, and TRPgamma showed
115  orthogonal alkyne handle into monoclonal or polyclonal antibodies from different species in an Fc-sp
116  neutralized HIV-2 pretreated with sCD4, and polyclonal antibodies from HIV-1-infected humans compete
117           A protocol for the purification of polyclonal antibodies from ovine serum using the synthet
118               Passive transfer of high-titer polyclonal antibodies from vaccinated Ebola virus-immune
119 uthentic virus from infected individuals and polyclonal antibodies from vaccinees.
120                  Western blotting using CHRC polyclonal antibody from bell pepper (Capsicum annuum) r
121  and a maize LTP-specific in-house developed polyclonal antibody from rabbit.
122                                              Polyclonal antibodies generated against GAUT1 immunoabso
123                                              Polyclonal antibodies generated against the amino or car
124                                              Polyclonal antibodies generated against the Ee;CDKF;1 pr
125                                              Polyclonal antibodies generated in goats were superior r
126 scent and electron microscopic studies using polyclonal antibodies generated to the recombinant c-ter
127  the protective efficacy of vaccine-elicited polyclonal antibodies has not previously been demonstrat
128 munosorbent assay showed that lunasin rabbit polyclonal antibody has a titer of 250 and a specific ac
129  using the conventional Ricin monoclonal and polyclonal antibodies have also been demonstrated for co
130                       Antigen-specific human polyclonal antibodies (hpAbs), produced by hyperimmuniza
131  when measured by the monoclonal but not the polyclonal antibody immunoassay.
132 nstrained peptides that recognize the BDE 47-polyclonal antibody immunocomplex were isolated.
133 n was used to create a reservoir of covalent polyclonal antibodies in 3 mouse strains that were subse
134 amplified via liposomes; (ii) the use of two polyclonal antibodies in the sandwich assay format incre
135 antibody sequences directly from circulating polyclonal antibodies in the serum of an immunized anima
136 lopment of a Tc goat system expressing human polyclonal antibodies in their sera.
137 is recombinant enzyme was used to generate a polyclonal antibody in rabbit that recognizes MnSOD in T
138  closely related toxin SEC(1) when we used a polyclonal antibody in the assay.
139 following transplantation and increased with polyclonal antibody induction therapy (IRR=1.65, 95% CI
140 ed for sex, age, transplant year, and use of polyclonal antibody induction.
141 tivated and neutralized alpha2beta1 integrin polyclonal antibodies, interleukin-1 receptor antagonist
142 icacious against ZIKV, suggesting this human polyclonal antibody is a viable candidate for further de
143                                              Polyclonal antibodies labeled with fluorescent nanoparti
144          A sandwich-type immunoassay using a polyclonal antibody labeled with peroxidase, hydrogen pe
145                   A mouse alpha-CadF peptide polyclonal antibody (M alpha-CadF peptide pAb) was gener
146  and many antibodies in an antihenipavirus-F polyclonal antibody mixture (pAb835) also target this re
147  derived from the antigen-binding domains of polyclonal antibody mixtures.
148                               An IP synthase polyclonal antibody not only detects the alpha and gamma
149 First, we evaluated a natural product, human polyclonal antibody, obtained as fresh frozen plasma (FF
150 zed electrodes that are surface treated with polyclonal antibodies of glyphosate and a custom electro
151  resonance (SPR) screening of monoclonal and polyclonal antibodies of Plasmodium falciparum (MoabPf a
152 MAF-1 fusion protein was used to produce the polyclonal antibody of rat.
153 ttached to the magnetic nanobeads and rabbit polyclonal antibodies on the SPR sensor surface.
154 ed using an immobilized goat anti-rabbit IgG polyclonal antibody on the SPR sensor chip.
155                       A rabbit antithymocyte polyclonal antibody or basiliximab, an interleukin-2 rec
156                                              Polyclonal antibodies (pAb-H3) prepared by injection of
157 as well as antibodies to HagB, including the polyclonal antibody (PAb) A7985 and the monoclonal antib
158 vely little is known about the extent of the polyclonal antibody (PAb) repertoire elicited by herpes
159                                        Human polyclonal antibodies (PAbs) are ideal, but this is depe
160  on commercial ELISA kits which are based on polyclonal antibodies (pAbs) not previously tested for c
161 ls after the addition of either RSV-specific polyclonal antibodies (PAbs) or RSV glycoprotein-specifi
162 oblotting after SDS-PAGE and Urea-PAGE using polyclonal antibodies (PABs) raised against 0.19 and 0.2
163 rabbits with FL1 or FL2 peptides to generate polyclonal antibodies (PAbs).
164  immunoassays (with the use of monoclonal or polyclonal antibodies), parathyroid hormone, and albumin
165 nally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S me
166                          Plasmablast-derived polyclonal antibodies (PPAb) from young and elderly reci
167 pecific plasmablasts and plasmablast-derived polyclonal antibodies (PPAbs) in IIV recipients were sig
168 mining the reactivity of plasmablast-derived polyclonal antibodies (PPAbs) to influenza proteins.
169                          Plasmablast-derived polyclonal antibodies (PPAbs) were generated from bulk-c
170 ylactic or therapeutic administration of the polyclonal antibody preparations (TcPAbs) can protect mi
171 nical efficacy of different batches of these polyclonal antibody preparations.
172      An anti-outer membrane protein A (OmpA) polyclonal antibody previously produced (in our laborato
173                     Botulism is treated with polyclonal antibodies produced in horses that are associ
174   We show here that B cell proliferation and polyclonal antibody production in response to Gram-negat
175  eventual amount of B cell proliferation and polyclonal antibody production.
176 3-A) raised to gonyautoxin 2/3, and a rabbit polyclonal antibody (R895) raised to saxitoxin (STX).
177                                              Polyclonal antibodies raised against a fat-body targetin
178 vel immunosensors have been fabricated using polyclonal antibodies raised against a human Ad (Ad5) ca
179                                              Polyclonal antibodies raised against Alt-ATXN1 confirmed
180                                              Polyclonal antibodies raised against certain fragments o
181                         Additionally, rabbit polyclonal antibodies raised against gB-DLD neutralized
182                                       Rabbit polyclonal antibodies raised against P3 prevented AgLDL
183                               Monoclonal and polyclonal antibodies raised against RagB1 of P. gingiva
184 ducts were identified by immunoblotting with polyclonal antibodies raised against recombinant chloros
185 o diagnostic test that utilizes a mixture of polyclonal antibodies raised against recombinant nucleop
186 had a 42 kD fusion protein immunoreactive to polyclonal antibodies raised against recombinant Solanum
187                                Two different polyclonal antibodies raised against sequences of the CT
188                               Monoclonal and polyclonal antibodies raised against the 30-residue pept
189             Previous studies have shown that polyclonal antibodies raised against the B5R ectodomain
190                                              Polyclonal antibodies raised against the M. bovis hemoly
191                                     Specific polyclonal antibodies raised in mice and rabbits reacted
192 ked immunosorbent assay and flow cytometry), polyclonal antibodies raised to recombinant SBP2 demonst
193                                            A polyclonal antibody raised against a unique peptide in t
194 ohistochemistry was performed using a rabbit polyclonal antibody raised against OFQ/N.
195                                    We used a polyclonal antibody raised against rat GABA(B)Rs in the
196                                     A rabbit polyclonal antibody raised against the putative recombin
197 as well as resistance to neutralization by a polyclonal antibody raised against the wild-type virus.
198  the two exudate isoforms is recognized by a polyclonal antibody raised to an Arabidopsis purple APas
199 fficiently exposed on the capsid surface for polyclonal antibody reactivity, while the small HA epito
200   By immunocytochemical staining, the rabbit polyclonal antibody recognized A2E that had accumulated
201   Characterizing the in vivo dynamics of the polyclonal antibody repertoire in serum, such as that wh
202 nd a rabbit anti-human von Willebrand factor polyclonal antibody, respectively.
203 SSTI with USA300, despite eliciting a strong polyclonal antibody response against antigens whose expr
204 has been confounded by the complexity of the polyclonal antibody response in humans.
205 ated protection correlated with induction of polyclonal antibody response that neutralized not only a
206 Env-specific IgA, as part of postvaccination polyclonal antibody response, may modulate vaccine-induc
207 nstrate the induction of functionally active polyclonal antibody responses as measured in the standar
208  we found that S. aureus SSTI elicited broad polyclonal antibody responses in both BALB/c and C57BL/6
209 mmunogenicity studies have mainly focused on polyclonal antibody responses in experimental animals.
210 lineating the epitope specificities found in polyclonal antibody responses to HIV-1 infection.
211                                      Mapping polyclonal antibody responses to infectious diseases to
212 immunogenicity studies revealed that similar polyclonal antibody responses were generated against ant
213 alizing activities, epitopes targeted by the polyclonal antibody responses were mapped and monoclonal
214 V-1 infection is associated with complex and polyclonal antibody responses, typically composed of mul
215 ion remains limited due to the complexity of polyclonal antibody responses.
216 ouse immunogenicity studies revealed similar polyclonal antibody responses.
217 o assess the quality of immunization-induced polyclonal antibody responses.
218 ivation of the innate immune system promotes polyclonal antibody secretion to eliminate invading path
219 eta(5) adapter ligands, the induced covalent polyclonal antibodies self-assembled with the adapter li
220                 Immunochemical staining with polyclonal antibodies showed that the addition of deterg
221           Immunohistochemistry with a custom polyclonal antibody showed staining localized to the inn
222 luorescence with a PAF-receptor (N terminus) polyclonal antibody showed that the receptor was express
223  and immunohistochemistry detection by HSV-1 polyclonal antibodies, showed a lack of viral proteins i
224 standard membrane-feeding assays, anti-FREP1 polyclonal antibodies significantly blocked transmission
225 agnetic nanoparticles (PMPs) conjugated with polyclonal antibodies specific for each antigen target,
226 ly responsible for the lack of inhibition by polyclonal antibodies specific for earlier strains.
227                    We use these reagents and polyclonal antibodies specific for EphB1, EphB2, EphB3,
228 ination in the amount and the avidity of the polyclonal antibodies specific for the HA1 subunit of th
229                                              Polyclonal antibodies specific to AR-V7 detected the AR-
230  we extend our observations using IHC with a polyclonal antibody specific for AC-K280.
231                 Immunohistochemistry using a polyclonal antibody specific for acetylated-tau at lysin
232                                      Using a polyclonal antibody specific for dll4, the development o
233                                Here we use a polyclonal antibody specific for the phosphorylated insu
234                       Furthermore, we have a polyclonal antibody specific to phospho-IRF4(Y121/124) d
235                                            A polyclonal antibody specific to PLS3 was raised to exami
236 ors (2 mm(2)) are prepared by immobilizing a polyclonal antibody specific to SEB, which was exposed t
237  the results of anatomical studies using our polyclonal antibody specifically against human melanopsi
238                         We generated a novel polyclonal antibody (SYN105) against the c-terminally tr
239 nding the fine specificity of monoclonal and polyclonal antibodies that bind the M antigen.
240        Here we describe a protocol to purify polyclonal antibodies that specifically detect the modif
241 sing an NFAT reporter assay, we identified a polyclonal antibody that activates EMR2 G protein signal
242                           In comparison to a polyclonal antibody that does not distinguish viable fro
243                             DAT is an equine polyclonal antibody that is not commercially available i
244 hat recognizes nonfibrillar oligomers; OC, a polyclonal antibody that recognizes amyloid fibrils of v
245                                To generate a polyclonal antibody that recognizes this pyridinium bisr
246                                            A polyclonal antibody that targets the beta-subunit of the
247                                      We used polyclonal antibodies, the TRAAK inhibitor RU2 and node
248 ess that frequently occurs in patients after polyclonal antibody therapy (ATGAM or thymoglobulin).
249                                     An ovine polyclonal antibody therapy has been developed against E
250 nsplant recipients with serum sickness after polyclonal antibody therapy may benefit from TPE by acce
251 ugh the extremely rapid generation of robust polyclonal antibody titers with remarkable specificity.
252                                        While polyclonal antibodies to aa 412 to 423 from HCV-infected
253 , conflicting findings have been reported on polyclonal antibodies to an adjacent region, aa 434 to 4
254                                              Polyclonal antibodies to B5 or B6 cross-reacted with the
255                                 In addition, polyclonal antibodies to F. nucleatum, which inhibited f
256                       Topical treatment with polyclonal antibodies to IL-17 resulted in significant r
257                 Treatment with monoclonal or polyclonal antibodies to PNAG (anti-PNAG) or vaccination
258 ment (Fab) of antivesicular stomatitis virus polyclonal antibodies to shield the virus from nAbs and
259                            Affinity-purified polyclonal antibodies to target antigen PhnD inhibited b
260                   We developed site-directed polyclonal antibodies to the N- or C-terminal regions of
261 lubilized alpha-elastin from human aorta and polyclonal antibodies to this antigen.
262 cochleae of different ages using custom-made polyclonal antibodies to TMC1 for light and transmission
263 LBD, AD, and LBV, we generated and validated polyclonal antibodies to truncated alpha-syn ending at r
264  the R5, G12 and Skerritt monoclonal and two polyclonal antibodies to well-defined gluten protein typ
265                  As a model system we used a polyclonal antibody to 3-phenoxybenzoic acid (3-PBA) and
266       Here, we generated and characterized a polyclonal antibody to a 13-amino-acid-long peptide sequ
267                      Consistent with this, a polyclonal antibody to CD55 captured cell culture-grown
268                       Topical treatment with polyclonal antibody to PVL yielded significant reduction
269                                            A polyclonal antibody to recombinant CD44v6 blocks migrati
270  applied together with a new anti-C-terminal polyclonal antibody to tear and tissue Western blotting.
271 fficacy/safety of two IV doses of AZD9773, a polyclonal antibody to tumor necrosis factor-alpha, in a
272 iple inflammatory conditions, and anti-HMGB1 polyclonal antibody treatment improves survival in a mod
273  patients who developed serum sickness after polyclonal antibody treatment with severe symptoms that
274                        Tumor necrosis factor polyclonal antibodies (two trials, n=151) and low-molecu
275 imab use (pOR =3.03 (1.82, 5.04); I =0%) and polyclonal antibodies use for rejection (pOR = 3.92 [1.8
276 e colostral anti-tumor necrosis factor (TNF) polyclonal antibody used in early clinical studies for t
277        Paraffin sections were stained with a polyclonal antibody using an immunoperoxidase technique.
278 sor chip was used to immobilise alpha-casein-polyclonal antibody using EDC/NHS coupling procedure.
279 ry with specific anti-keratin monoclonal and polyclonal antibodies was used to examine AW in normal h
280 e motif) autoantigen that is recognized by a polyclonal antibody was determined as assembling an "L-E
281 ter STNS and neuroendocrine organs, a rabbit polyclonal antibody was generated against synthetic Val(
282 isting of saporin conjugated to a melanopsin polyclonal antibody, was evaluated with respect to its e
283                   Using antisense probes and polyclonal antibodies, we show that col14a1a and its pro
284                            Antiphosphoserine polyclonal antibodies were anchored on amorphous magneti
285                  Additionally, the HuMab and polyclonal antibodies were exploited to investigate the
286                                              Polyclonal antibodies were generated against OTC molecul
287                                              Polyclonal antibodies were generated from synthetic pept
288                                              Polyclonal antibodies were made to two synthetic peptide
289 ned monoclonal (outer surface protein A) and polyclonal antibodies were performed on all tissue secti
290                                   High titer polyclonal antibodies were produced in rabbit against a
291                                              Polyclonal antibodies were produced to specifically dete
292                                              Polyclonal antibodies were raised against FN and three d
293                    For these studies, rabbit polyclonal antibodies were raised against two peptide se
294                                              Polyclonal antibodies were raised against unique C-termi
295               Two anti-CB2 affinity purified polyclonal antibodies were raised in rabbits immunized w
296                                        Ovine polyclonal antibodies were raised using an immunogen mad
297 iously, we have demonstrated that B virus gD polyclonal antibodies were unable to neutralize B virus
298 brillin-1 null tissues, using monoclonal and polyclonal antibodies with defined epitopes, demonstrate
299 of EBOV-Zaire/Makona produced anti-Ebola IgG polyclonal antibodies with high neutralization activity.
300                             For this, rabbit polyclonal antibody with specificity to C. jejuni was fi

 
Page Top